VM

Vibha Madhukar Bante

Active Director Director DIN 10077550
DIN 10077550 First appointment Mar 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Vibha Madhukar Bante

Data last updated:

Vibha Madhukar Bante is a Director at Fourmost Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Fourmost Pharmaceuticals Private Limited reported revenue of ₹49.4 Lakh (FY 2025).

DIN 10077550
Primary Designation Director
Industry Pharma
First Appointment 17 Mar 2023
Oldest Company Age 3 yrs
Largest company Fourmost Pharmaceuticals Private Limited · ₹49.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Mar 20232023₹49.4 Lakh (FY 2025)Active

Board colleagues of Vibha Madhukar Bante

Directorship timeline

Open interactive timeline →
Fourmost Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Vibha Madhukar Bante

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vibha Madhukar Bante

Vibha Madhukar Bante currently holds 1 directorship: Fourmost Pharmaceuticals Private Limited (Director, since 17 Mar 2023, revenue ₹49.4 Lakh (FY 2025)).

Vibha Madhukar Bante was first appointed on 17 Mar 2023 as Director at Fourmost Pharmaceuticals Private Limited.

The current boards of Vibha Madhukar Bante's companies include Madhukar Madhavrao Gotmare (Fourmost Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available